Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
<strong>Background</strong> Tafenoquine, a single-dose therapy for Plasmodium vivax malaria, has been associated with relapse prevention through the clearance of P. vivax parasitemia and hypnozoites, termed “radical cure.” <strong>Methods</strong> We performed a phase 3, pro...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Massachusetts Medical Society
2019
|